{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T23:48:40Z","timestamp":1768348120654,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,10,9]],"date-time":"2013-10-09T00:00:00Z","timestamp":1381276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,10,9]],"date-time":"2013-10-09T00:00:00Z","timestamp":1381276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1038\/leu.2013.291","type":"journal-article","created":{"date-parts":[[2013,10,9]],"date-time":"2013-10-09T10:09:18Z","timestamp":1381313358000},"page":"880-887","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["MicroRNA187 overexpression is related to tumor progression and determines sensitivity to bortezomib in peripheral T-cell lymphoma"],"prefix":"10.1038","volume":"28","author":[{"given":"Z-X","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L-L","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q-L","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Leboeuf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Janin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S-J","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W-L","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,9]]},"reference":[{"key":"BFleu2013291_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/leu.2009.223","volume":"24","author":"WL Zhao","year":"2010","unstructured":"Zhao WL . Targeted therapy in T-cell malignancies: dysregulation of the cellular signaling pathways. Leukemia 2010; 24: 13\u201321.","journal-title":"Leukemia"},{"key":"BFleu2013291_CR2","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1172\/JCI37210","volume":"121","author":"X Wang","year":"2011","unstructured":"Wang X, Werneck MB, Wilson BG, Kim HJ, Kluk MJ, Thom CS et al. TCR-dependent transformation of mature memory phenotype T cells in mice. J Clin Invest 2011; 121: 3834\u20133845.","journal-title":"J Clin Invest"},{"key":"BFleu2013291_CR3","doi-asserted-by":"publisher","first-page":"6650","DOI":"10.1182\/blood-2011-02-336842","volume":"117","author":"M Bonnet","year":"2011","unstructured":"Bonnet M, Loosveld M, Montpellier B, Navarro JM, Quilichini B, Picard C et al. Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia. Blood 2011; 117: 6650\u20136659.","journal-title":"Blood"},{"key":"BFleu2013291_CR4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1532\/IJH97.06165","volume":"85","author":"D Shimizu","year":"2007","unstructured":"Shimizu D, Taki T, Utsunomiya A, Nakagawa H, Nomura K, Matsumoto Y et al. Detection of NOTCH1 mutations in adult T-cell leukemia\/lymphoma and peripheral T-cell lymphoma. Int J Hematol 2007; 85: 212\u2013218.","journal-title":"Int J Hematol"},{"key":"BFleu2013291_CR5","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/onc.2009.512","volume":"29","author":"WC Gustafson","year":"2010","unstructured":"Gustafson WC, Weiss WA . Myc proteins as therapeutic targets. Oncogene 2010; 29: 1249\u20131259.","journal-title":"Oncogene"},{"key":"BFleu2013291_CR6","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1158\/0008-5472.CAN-11-3605","volume":"72","author":"WB Tsai","year":"2012","unstructured":"Tsai WB, Aiba I, Long Y, Lin HK, Feun L, Savaraj N et al. Activation of Ras\/PI3K\/ERK pathway induces c-Myc stabilization to upregulate argininosuccinate synthetase, leading to arginine deiminase resistance in melanoma cells. Cancer Res 2012; 72: 2622\u20132633.","journal-title":"Cancer Res"},{"key":"BFleu2013291_CR7","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1038\/sj.onc.1206394","volume":"22","author":"C Knuefermann","year":"2003","unstructured":"Knuefermann C, Lu Y, Liu B, Jin W, Liang K, Wu L et al. HER2\/PI-3K\/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells. Oncogene 2003; 22: 3205\u20133212.","journal-title":"Oncogene"},{"key":"BFleu2013291_CR8","doi-asserted-by":"publisher","first-page":"17065","DOI":"10.1074\/jbc.M112.349365","volume":"287","author":"D Naci","year":"2012","unstructured":"Naci D, El Azreq MA, Chetoui N, Lauden L, Sigaux F, Charron D et al. alpha2beta1 integrin promotes chemoresistance against doxorubicin in cancer cells through extracellular signal-regulated kinase (ERK). J Biol Chem 2012; 287: 17065\u201317076.","journal-title":"J Biol Chem"},{"key":"BFleu2013291_CR9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1749-6632.2012.06745.x","volume":"1271","author":"D Lee","year":"2012","unstructured":"Lee D, Shin C . MicroRNA-target interactions: new insights from genome-wide approaches. Ann N Y Acad Sci 2012; 1271: 118\u2013128.","journal-title":"Ann N Y Acad Sci"},{"key":"BFleu2013291_CR10","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.1158\/0008-5472.CAN-10-0659","volume":"70","author":"JW Kim","year":"2010","unstructured":"Kim JW, Mori S, Nevins JR . Myc-induced microRNAs integrate Myc-mediated cell proliferation and cell fate. Cancer Res 2010; 70: 4820\u20134828.","journal-title":"Cancer Res"},{"key":"BFleu2013291_CR11","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/onc.2011.269","volume":"31","author":"A Chao","year":"2012","unstructured":"Chao A, Lin CY, Lee YS, Tsai CL, Wei PC, Hsueh S et al. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2. Oncogene 2012; 31: 764\u2013775.","journal-title":"Oncogene"},{"key":"BFleu2013291_CR12","doi-asserted-by":"publisher","first-page":"6702","DOI":"10.1158\/1078-0432.CCR-12-1420","volume":"18","author":"L Mulrane","year":"2012","unstructured":"Mulrane L, Madden SF, Brennan DJ, Gremel G, McGee SF, McNally S et al. miR-187 is an independent prognostic factor in breast cancer and confers increased invasive potential in vitro. Clin Cancer Res 2012; 18: 6702\u20136713.","journal-title":"Clin Cancer Res"},{"key":"BFleu2013291_CR13","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1210\/jc.2007-2696","volume":"93","author":"MN Nikiforova","year":"2008","unstructured":"Nikiforova MN, Tseng GC, Steward D, Diorio D, Nikiforov YE . MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J Clin Endocrinol Metab 2008; 93: 1600\u20131608.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFleu2013291_CR14","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1182\/asheducation-2009.1.523","volume":"2009","author":"ES Jaffe","year":"2009","unstructured":"Jaffe ES . The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program 2009; 2009: 523\u2013531.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"BFleu2013291_CR15","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/leu.2012.269","volume":"27","author":"DJ Min","year":"2012","unstructured":"Min DJ, Ezponda T, Kim MK, Will CM, Martinez-Garcia E, Popovic R et al. MMSET stimulates myeloma cell growth through microRNA-mediated modulation of c-MYC. Leukemia 2012; 27: 686\u2013694.","journal-title":"Leukemia"},{"key":"BFleu2013291_CR16","doi-asserted-by":"publisher","first-page":"9906","DOI":"10.1158\/0008-5472.CAN-05-1481","volume":"65","author":"J Zhoul","year":"2005","unstructured":"Zhoul J, Hernandez G, Tu SW, Huang CL, Tseng CP, Hsieh JT . The role of DOC-2\/DAB2 in modulating androgen receptor-mediated cell growth via the nongenomic c-Src-mediated pathway in normal prostatic epithelium and cancer. Cancer Res 2005; 65: 9906\u20139913.","journal-title":"Cancer Res"},{"key":"BFleu2013291_CR17","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1182\/blood-2009-06-227579","volume":"115","author":"J Iqbal","year":"2010","unstructured":"Iqbal J, Weisenburger DD, Greiner TC, Vose JM, McKeithan T, Kucuk C et al. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood 2010; 115: 1026\u20131036.","journal-title":"Blood"},{"key":"BFleu2013291_CR18","doi-asserted-by":"publisher","first-page":"6627","DOI":"10.1182\/blood-2010-09-301994","volume":"117","author":"C Desjobert","year":"2011","unstructured":"Desjobert C, Renalier MH, Bergalet J, Dejean E, Joseph N, Kruczynski A et al. MiR-29a down-regulation in ALK-positive anaplastic large cell lymphomas contributes to apoptosis blockade through MCL-1 overexpression. Blood 2011; 117: 6627\u20136637.","journal-title":"Blood"},{"key":"BFleu2013291_CR19","doi-asserted-by":"publisher","first-page":"16228","DOI":"10.1073\/pnas.1009719107","volume":"107","author":"O Merkel","year":"2010","unstructured":"Merkel O, Hamacher F, Laimer D, Sifft E, Trajanoski Z, Scheideler M et al. Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma. Proc Natl Acad Sci USA 2010; 107: 16228\u201316233.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2013291_CR20","doi-asserted-by":"publisher","first-page":"27793","DOI":"10.1074\/jbc.M102803200","volume":"276","author":"J Zhou","year":"2001","unstructured":"Zhou J, Hsieh JT . The inhibitory role of DOC-2\/DAB2 in growth factor receptor-mediated signal cascade. DOC-2\/DAB2-mediated inhibition of ERK phosphorylation via binding to Grb2. J Biol Chem 2001; 276: 27793\u201327798.","journal-title":"J Biol Chem"},{"key":"BFleu2013291_CR21","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1158\/0008-5472.CAN-08-1982","volume":"69","author":"MD Castellone","year":"2009","unstructured":"Castellone MD, De Falco V, Rao DM, Bellelli R, Muthu M, Basolo F et al. The beta-catenin axis integrates multiple signals downstream from RET\/papillary thyroid carcinoma leading to cell proliferation. Cancer Res 2009; 69: 1867\u20131876.","journal-title":"Cancer Res"},{"key":"BFleu2013291_CR22","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1101\/gad.836800","volume":"14","author":"R Sears","year":"2000","unstructured":"Sears R, Nuckolls F, Haura E, Taya Y, Tamai K, Nevins JR . Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev 2000; 14: 2501\u20132514.","journal-title":"Genes Dev"},{"key":"BFleu2013291_CR23","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.4161\/cc.3.9.1145","volume":"3","author":"RC Sears","year":"2004","unstructured":"Sears RC . The life cycle of C-myc: from synthesis to degradation. Cell Cycle 2004; 3: 1133\u20131137.","journal-title":"Cell Cycle"},{"key":"BFleu2013291_CR24","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/leu.2008.26","volume":"22","author":"LS Steelman","year":"2008","unstructured":"Steelman LS, Abrams SL, Whelan J, Bertrand FE, Ludwig DE, Basecke J et al. Contributions of the Raf\/MEK\/ERK, PI3K\/PTEN\/Akt\/mTOR and Jak\/STAT pathways to leukemia. Leukemia 2008; 22: 686\u2013707.","journal-title":"Leukemia"},{"key":"BFleu2013291_CR25","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/hep.25776","volume":"56","author":"EK Chow","year":"2012","unstructured":"Chow EK, Fan LL, Chen X, Bishop JM . Oncogene-specific formation of chemoresistant murine hepatic cancer stem cells. Hepatology 2012; 56: 1331\u20131341.","journal-title":"Hepatology"},{"key":"BFleu2013291_CR26","doi-asserted-by":"publisher","first-page":"6227","DOI":"10.1182\/blood-2010-10-312231","volume":"117","author":"VJ Craig","year":"2011","unstructured":"Craig VJ, Cogliatti SB, Imig J, Renner C, Neuenschwander S, Rehrauer H et al. Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1. Blood 2011; 117: 6227\u20136236.","journal-title":"Blood"},{"key":"BFleu2013291_CR27","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1177\/0300060512474128","volume":"41","author":"C Zheng","year":"2013","unstructured":"Zheng C, Jiao X, Jiang Y, Sun S . ERK1\/2 activity contributes to gemcitabine resistance in pancreatic cancer cells. J Int Med Res 2013; 41: 300\u2013306.","journal-title":"J Int Med Res"},{"key":"BFleu2013291_CR28","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1007\/s10495-009-0372-4","volume":"14","author":"C Nishioka","year":"2009","unstructured":"Nishioka C, Ikezoe T, Yang J, Yokoyama A . Inhibition of MEK signaling enhances the ability of cytarabine to induce growth arrest and apoptosis of acute myelogenous leukemia cells. Apoptosis 2009; 14: 1108\u20131120.","journal-title":"Apoptosis"},{"key":"BFleu2013291_CR29","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1200\/JCO.2009.26.3947","volume":"28","author":"S Barrans","year":"2010","unstructured":"Barrans S, Crouch S, Smith A, Turner K, Owen R, Patmore R et al. Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab. J Clin Oncol 2010; 28: 3360\u20133365.","journal-title":"J Clin Oncol"},{"key":"BFleu2013291_CR30","doi-asserted-by":"publisher","first-page":"4400","DOI":"10.1182\/blood-2012-05-428466","volume":"120","author":"M Gupta","year":"2012","unstructured":"Gupta M, Maurer MJ, Wellik LE, Law ME, Han JJ, Ozsan N et al. Expression of Myc, but not pSTAT3, is an adverse prognostic factor for diffuse large B-cell lymphoma treated with epratuzumab\/R-CHOP. Blood 2012; 120: 4400\u20134406.","journal-title":"Blood"},{"key":"BFleu2013291_CR31","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1016\/j.ejca.2012.06.003","volume":"48","author":"SJ Kim","year":"2012","unstructured":"Kim SJ, Yoon DH, Kang HJ, Kim JS, Park SK, Kim HJ et al. Bortezomib in combination with CHOP as first-line treatment for patients with stage III\/IV peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 trial. Eur J Cancer 2012; 48: 3223\u20133231.","journal-title":"Eur J Cancer"},{"key":"BFleu2013291_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00109-011-0805-8","volume":"90","author":"CD Befani","year":"2012","unstructured":"Befani CD, Vlachostergios PJ, Hatzidaki E, Patrikidou A, Bonanou S, Simos G et al. Erratum to: Bortezomib represses HIF-1alpha protein expression and nuclear accumulation by inhibiting both PI3K\/Akt\/TOR and MAPK pathways in prostate cancer cells. J Mol Med (Berl) 2012; 90: 45\u201354, (published erratum appears in J Mol Med (Berl) 2013; 91: 771\u2013773).","journal-title":"J Mol Med (Berl)"},{"key":"BFleu2013291_CR33","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1038\/bcj.2012.31","volume":"2","author":"E Ballabio","year":"2012","unstructured":"Ballabio E, Armesto M, Breeze CE, Manterola L, Arestin M, Tramonti D et al. Bortezomib action in multiple myeloma: microRNA-mediated synergy (and miR-27a\/CDK5 driven sensitivity)? Blood Cancer J 2012; 2: e83.","journal-title":"Blood Cancer J"},{"key":"BFleu2013291_CR34","doi-asserted-by":"publisher","first-page":"e59390","DOI":"10.1371\/journal.pone.0059390","volume":"8","author":"V Manfe","year":"2013","unstructured":"Manfe V, Biskup E, Willumsgaard A, Skov AG, Palmieri D, Gasparini P et al. cMyc\/miR-125b-5p Signalling Determines Sensitivity to Bortezomib in Preclinical Model of Cutaneous T-Cell Lymphomas. PLoS One 2013; 8: e59390.","journal-title":"PLoS One"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2013291.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2013291","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2013291.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T15:23:56Z","timestamp":1648740236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2013291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,9]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["BFleu2013291"],"URL":"https:\/\/doi.org\/10.1038\/leu.2013.291","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,9]]},"assertion":[{"value":"28 May 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}